Section Arrow
MMED.NASDAQ
- MiniMed Group, Inc.
Quotes are at least 15-min delayed:2026/11/05 00:58 EST
Regular Hours
Last
 19.29
+0.44 (+2.33%)
Day High 
19.925 
Prev. Close
18.85 
1-M High
20.17 
Volume 
11.78M 
Bid
18
Ask
19.95
Day Low
19.11 
Open
19.33 
1-M Low
16.555 
Market Cap 
5.30B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 18.65 
20-SMA 18.5 
50-SMA 20.1 
52-W High 24.43 
52-W Low 10.65 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.12/--
Enterprise Value
5.33B
Balance Sheet
Book Value Per Share
12.87
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.72B
Operating Revenue Per Share
0.44
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MDLNMedline Inc40.35+6.26+18.36%42.65PE
MMEDMiniMed Group, Inc.19.29+0.44+2.33%-- 
BAXBaxter International26.5+1.01+3.96%-- 
AVTRAvantor15.65+0.06+0.38%31.18PE
WRBYWarby Parker21.29-0.65-2.96%365.67PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.